About Clyde Pharmaceutical Private Limited
Data last updated:
Clyde Pharmaceutical Private Limited is a private limited company based in Bishrakh, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U47721UP2011PTC234959. Its GSTIN is 07AAECC6442R1Z5 (Delhi).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vishnu Dutta Agrawal and Purnima Adlakha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bishrakh, Uttar Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.38 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹38.88 Lakh (net margin 16.4%) and EBITDA of ₹52.44 Lakh (EBITDA margin 22.1%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 21% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website clydepharma.in.
Company details
CIN history
Clyde Pharmaceutical has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U47721UP2011PTC234959, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U47721UP2011PTC234959 | Current |
| U74900MH2011PTC223301 | Previous |
| U47721MH2011PTC223301 | Previous |
Contact details
Clyde Pharmaceutical Private Limited's registered office is in Bishrakh, Uttar Pradesh.
- Registered AddressUnit No 1305 Tower – G Fusion Homes, Plot No Gh – 05 A Techzone – IV, Bishrakh, Uttar Pradesh, India – 201306
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Clyde Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Clyde Pharmaceutical Private Limited, buy the company report.
Financials of Clyde Pharmaceutical Private Limited
FY 2025 filings availableClyde Pharmaceutical Private Limited reported revenue of ₹2.38 Cr (up 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 21% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.1% | ||||
| Net Profit Margin | 16.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clyde Pharmaceutical Private Limited, buy the company report.
Board of directors of Clyde Pharmaceutical Private Limited
Clyde Pharmaceutical has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnu Dutta Agrawal Also directs: Divyam High End Products Private Limited | Director | 14 Jun 2012 | 14 Years 4 Months | Current |
| Purnima Adlakha | Director | 20 Oct 2011 | 15 Years 0 Months | Current |
| Kuldeep Kumar | Director | 24 Apr 2023 | 3 Years 6 Months | Current |
| Neelam Suri | Director | 10 Mar 2014 | 12 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Clyde Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clyde Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Clyde Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECC6442R1Z5 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Clyde Pharmaceutical Private Limited, buy the company report.
Recent activity
Clyde Pharmaceutical Private Limited has 7 board changes on record since 2011: 4 appointments and 3 cessations. The latest: Kuldeep Kumar was appointed as Director on 24 Apr 2023.
Frequently asked questions
Clyde Pharmaceutical is an active private limited company based in Bishrakh, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 October 2011 (15+ years old) and is registered under CIN U47721UP2011PTC234959.
Clyde Pharmaceutical has 4 current directors:
- Vishnu Dutta Agrawal - Director
- Purnima Adlakha - Director
- Kuldeep Kumar - Director
- Neelam Suri - Director
The latest financial statements of Clyde Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Clyde Pharmaceutical is 07AAECC6442R1Z5, registered in Delhi.
The CIN (Corporate Identification Number) of Clyde Pharmaceutical is U47721UP2011PTC234959. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clyde Pharmaceutical was incorporated on 20 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
Kuldeep Kumar was appointed as Director on 24 Apr 2023. Sarvodaya Chitkara ceased to be Director on 13 Mar 2019. Kuldeep Kumar ceased to be Director on 30 Aug 2018. Clyde Pharmaceutical has 7 board changes on record in total.
Clyde Pharmaceutical can be reached through the website clydepharma.in. Its registered office is in Bishrakh, Uttar Pradesh, India.
The registered office of Clyde Pharmaceutical is at Unit No 1305 Tower – G Fusion Homes, Plot No Gh – 05 A Techzone – IV, Bishrakh, Uttar Pradesh, India – 201306.
Clyde Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
